# A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications

> **NIH NIH N43** · INTRALYTIX, INC. · 2021 · $299,672

## Abstract

A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications.

## Key facts

- **NIH application ID:** 10497050
- **Project number:** 75N93021C00034-0-9999-1
- **Recipient organization:** INTRALYTIX, INC.
- **Principal Investigator:** MEL RUZICKA
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $299,672
- **Award type:** —
- **Project period:** 2021-08-16 → 2022-08-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10497050

## Citation

> US National Institutes of Health, RePORTER application 10497050, A universal, scale-independent artificial intelligence-based platform for manufacturing high titer bacteriophage preparations for clinical applications (75N93021C00034-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10497050. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*